About: The Effects of Co-admin of Colesevelam and Sitagliptin on Glucose Metabolism in Subjects With Type 2 Diabetes Mellitus

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: The Effects of Co-admin of Colesevelam and Sitagliptin on Glucose Metabolism in Subjects With Type 2 Diabetes Mellitus Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

clinical trial

Attributes	Values
rdf:type	Item
description	assaig clínic (ca) clinical trial (en) clinical trial (en-ca) clinical trial (en-gb) clinical trial (en-us) ensaio clínico (gl) ensayo clínico (es) ensayu clínicu (ast) essai clinique (fr) klinisch onderzoek (nl) клінічне випробування (uk)
rdfs:label	The Effects of Co-admin of Colesevelam and Sitagliptin on Glucose Metabolism in Subjects With Type 2 Diabetes Mellitus (en)
skos:prefLabel	The Effects of Co-admin of Colesevelam and Sitagliptin on Glucose Metabolism in Subjects With Type 2 Diabetes Mellitus (en)
name	The Effects of Co-admin of Colesevelam and Sitagliptin on Glucose Metabolism in Subjects With Type 2 Diabetes Mellitus (en)
title	wds:Q61936954-AFF356F6-C9D9-485F-9086-89594285C42A
title	The Effects of Co-administration of Colesevelam and Sitagliptin on Glucose Metabolism in Patients With Type 2 Diabetes (en)
end time	wds:Q61936954-EBC251BB-66F4-4E50-B6E4-F1D84274FCF3
end time	2011-07-01 00:00:00Z (xsd:dateTime)
instance of	wds:Q61936954-FA75B1C7-466D-4913-A1A4-62C584D103DB
instance of	clinical trial
start time	wds:Q61936954-8C869E62-C39B-48B5-9211-A7AE20286387
start time	2010-03-01 00:00:00Z (xsd:dateTime)
country	wds:Q61936954-40E1EB81-5D92-4FA6-AAE0-6553754366EA
country	United States of America
research site	wds:Q61936954-E45A758F-F0A8-4B06-8B18-D6570B7D05EE wds:Q61936954-F6A5868E-FF67-41DA-BCDC-1E9CEEA02818
research site	University of California, San Francisco Clinical Pharmacology of Miami
research intervention	wds:Q61936954-56ADE928-2E20-4638-BBA5-E54683062FF0
research intervention	sitagliptin phosphate
minimum age	wds:Q61936954-51EA4597-A9AB-4B66-9DC8-515A195D4AEF
minimum age	18 (xsd:decimal)
medical condition	wds:Q61936954-09571178-9F31-4DEE-A886-6A4B5DF08524
sponsor	wds:Q61936954-646458BC-59D5-4926-BC75-1AD63173E753
medical condition	diabetes
sponsor	KineMed (United States)
number of participants	wds:Q61936954-2BA2951E-5A45-4D6B-8D3A-4F878249F806
number of participants	61 (xsd:decimal)
maximum age	wds:Q61936954-F36138AD-931B-4ABB-B0A2-129E1D66EA96
maximum age	80 (xsd:decimal)
study type	wds:Q61936954-5E0A68CB-DAD0-44F6-A46E-F39816242F02
study type	interventional study
ClinicalTrials.gov ID	wds:Q61936954-F2A36CFA-ADA4-4730-9925-59850A432348
ClinicalTrials.gov ID	NCT01092663
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q61936954

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software